Alvotech
Biologics & Biosimilars · Health Care

Alvotech news and milestones

Alvotech: 10 headlines on record, 9 headlines in the last 90 days. Its story counts 1 milestone.

Data updated Nov 20, 2026 · Back to the company report
10Headlines
9In 90 days
1Milestones

Milestones

Nov 2026
Went public NASDAQ: ALVO
Each milestone is dated by its source: registers, filings, the press

Newsroom

#738,755Web rankTranco top 1M
Oct 212026
Press release · The Globe and Mail
Detailed price information for Alvotech (ALVO-Q) from The Globe and Mail including charting and trades.
Oct 202026
News · Barclays raises target for Alvotech stock to USD 8.00
Barclays set a USD 8.00 target on September 16, 2026. Alvotech stock costs EUR 4.56 on October 20, 2026; Nasdaq ALVO rose 1.79 percent.
Oct 202026
News · markets.businessinsider.com
REYKJAVIK, Iceland and LONDON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing ...
Oct 202026
News · RTTNews
Alvotech (ALVO) announced that the U.S. FDA has approved a new manufacturing process for SIMLANDI (adalimumab-ryvk), the company's biosimilar version of Humira, allowing producti…
Oct 202026
News · FinanzNachrichten.de
Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech's biosimilars portfolio REYKJAVIK, Iceland and LONDON, UK (O…
Sources: the outlets named on each headline, each story once

Headlines

Oct 212026
Press release · The Globe and Mail
Detailed price information for Alvotech (ALVO-Q) from The Globe and Mail including charting and trades.
Oct 202026
News · Barclays raises target for Alvotech stock to USD 8.00
Barclays set a USD 8.00 target on September 16, 2026. Alvotech stock costs EUR 4.56 on October 20, 2026; Nasdaq ALVO rose 1.79 percent.
Oct 202026
News · markets.businessinsider.com
REYKJAVIK, Iceland and LONDON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing ...
Oct 202026
News · RTTNews
Alvotech (ALVO) announced that the U.S. FDA has approved a new manufacturing process for SIMLANDI (adalimumab-ryvk), the company's biosimilar version of Humira, allowing producti…
Oct 202026
News · FinanzNachrichten.de
Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech's biosimilars portfolio REYKJAVIK, Iceland and LONDON, UK (O…
Oct 172026
News · YahooFinance
Alvotech and Advanz Pharma previously submitted a European regulatory application for AVT29, a proposed biosimilar to Eylea 8 mg, as a line extension to the approved Mynzepli mar…
Oct 152026
Press release · The Globe and Mail
Detailed price information for Alvotech (ALVO-Q) from The Globe and Mail including charting and trades.
Oct 62026
News · YahooFinance
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York Strategic long-term partnership to increase Alvotech's glob…
Sources: the outlets named on each headline, each story once

Milestones

Nov 2026
Went public NASDAQ: ALVO
Each milestone is dated by its source: registers, filings, the press

How to cite

Alvotech, News. Alion, Nov 20, 2026. https://alion.io/company/alvotech/news

.json · .md · CC BY-SA 4.0